These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 26695835)

  • 1. Harnessing the trophic and modulatory potential of statins in a dopaminergic cell line.
    Schmitt M; Dehay B; Bezard E; Garcia-Ladona FJ
    Synapse; 2016 Mar; 70(3):71-86. PubMed ID: 26695835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. U18666A, an activator of sterol regulatory element binding protein pathway, modulates presynaptic dopaminergic phenotype of SH-SY5Y neuroblastoma cells.
    Schmitt M; Dehay B; Bezard E; Garcia-Ladona FJ
    Synapse; 2017 Sep; 71(9):. PubMed ID: 28407359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopaminergic Neuronal Differentiation from the Forebrain-Derived Human Neural Stem Cells Induced in Cultures by Using a Combination of BMP-7 and Pramipexole with Growth Factors.
    Yang H; Wang J; Wang F; Liu X; Chen H; Duan W; Qu T
    Front Neural Circuits; 2016; 10():29. PubMed ID: 27147976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acrylamide increases dopamine levels by affecting dopamine transport and metabolism related genes in the striatal dopaminergic system.
    Pan X; Guo X; Xiong F; Cheng G; Lu Q; Yan H
    Toxicol Lett; 2015 Jul; 236(1):60-8. PubMed ID: 25943760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased vesicular monoamine transporter 2 (VMAT2) and dopamine transporter (DAT) function in knockout mice affects aging of dopaminergic systems.
    Hall FS; Itokawa K; Schmitt A; Moessner R; Sora I; Lesch KP; Uhl GR
    Neuropharmacology; 2014 Jan; 76 Pt A(0 0):146-55. PubMed ID: 23978383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo overexpression of synaptogyrin-3 promotes striatal synaptic dopamine uptake in LRRK2
    Ho PW; Li L; Liu HF; Choi ZY; Chang EES; Pang SY; Malki Y; Leung CT; Kung MH; Ramsden DB; Ho SL
    Brain Behav; 2023 Feb; 13(2):e2886. PubMed ID: 36624932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The 5α-reductase inhibitor Dutasteride but not Finasteride protects dopamine neurons in the MPTP mouse model of Parkinson's disease.
    Litim N; Bourque M; Al Sweidi S; Morissette M; Di Paolo T
    Neuropharmacology; 2015 Oct; 97():86-94. PubMed ID: 26006269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vesicular monoamine transporter 2 regulates the sensitivity of rat dopaminergic neurons to disturbed cytosolic dopamine levels.
    Vergo S; Johansen JL; Leist M; Lotharius J
    Brain Res; 2007 Dec; 1185():18-32. PubMed ID: 18028884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptional Regulation of the Synaptic Vesicle Protein Synaptogyrin-3 (
    Li L; Ho PW; Liu H; Pang SY; Chang EE; Choi ZY; Malki Y; Kung MH; Ramsden DB; Ho SL
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A fluorescent-based assay for live cell, spatially resolved assessment of vesicular monoamine transporter 2-mediated neurotransmitter transport.
    Bernstein AI; Stout KA; Miller GW
    J Neurosci Methods; 2012 Aug; 209(2):357-66. PubMed ID: 22698664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of dopamine and vesicular monoamine transporters and differential vulnerability of mesostriatal dopaminergic neurons.
    González-Hernández T; Barroso-Chinea P; De La Cruz Muros I; Del Mar Pérez-Delgado M; Rodríguez M
    J Comp Neurol; 2004 Nov; 479(2):198-215. PubMed ID: 15452855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial complex I inhibitor rotenone inhibits and redistributes vesicular monoamine transporter 2 via nitration in human dopaminergic SH-SY5Y cells.
    Watabe M; Nakaki T
    Mol Pharmacol; 2008 Oct; 74(4):933-40. PubMed ID: 18599602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physical and functional interaction between the dopamine transporter and the synaptic vesicle protein synaptogyrin-3.
    Egaña LA; Cuevas RA; Baust TB; Parra LA; Leak RK; Hochendoner S; Peña K; Quiroz M; Hong WC; Dorostkar MM; Janz R; Sitte HH; Torres GE
    J Neurosci; 2009 Apr; 29(14):4592-604. PubMed ID: 19357284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulatory effects of costunolide on dopamine metabolism-associated genes inhibit dopamine-induced apoptosis in human dopaminergic SH-SY5Y cells.
    Ham A; Lee SJ; Shin J; Kim KH; Mar W
    Neurosci Lett; 2012 Jan; 507(2):101-5. PubMed ID: 22040670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phytic acid attenuates upregulation of GSK-3β and disturbance of synaptic vesicle recycling in MPTP-induced Parkinson's disease models.
    Wang L; Zhang Z; Hou L; Wang Y; Zuo J; Xue M; Li X; Liu Y; Song J; Pan F; Pu T
    Neurochem Int; 2019 Oct; 129():104507. PubMed ID: 31325476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perinatal heptachlor exposure increases expression of presynaptic dopaminergic markers in mouse striatum.
    Caudle WM; Richardson JR; Wang M; Miller GW
    Neurotoxicology; 2005 Aug; 26(4):721-728. PubMed ID: 16112329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Puerarin protects dopaminergic neurons in Parkinson's disease models.
    Zhang X; Xiong J; Liu S; Wang L; Huang J; Liu L; Yang J; Zhang G; Guo K; Zhang Z; Wu P; Wang D; Lin Z; Xiong N; Wang T
    Neuroscience; 2014 Nov; 280():88-98. PubMed ID: 25218963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of the Dopamine and Vesicular Monoamine Transporters: Pharmacological Targets and Implications for Disease.
    German CL; Baladi MG; McFadden LM; Hanson GR; Fleckenstein AE
    Pharmacol Rev; 2015 Oct; 67(4):1005-24. PubMed ID: 26408528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human caspase 7 is positively controlled by SREBP-1 and SREBP-2.
    Gibot L; Follet J; Metges JP; Auvray P; Simon B; Corcos L; Le Jossic-Corcos C
    Biochem J; 2009 May; 420(3):473-83. PubMed ID: 19323650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ginkgo biloba extract (EGb 761) modulates the expression of dopamine-related genes in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice.
    Rojas P; Ruiz-Sánchez E; Rojas C; Ogren SO
    Neuroscience; 2012 Oct; 223():246-57. PubMed ID: 22885234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.